Evidence map›Paper›PMID 30867223›Full record

ArticleLife science alliance2019

Expanding the repertoire of glucocorticoid receptor target genes by engineering genomic response elements.

Verena Thormann, Laura V Glaser, Maika C Rothkegel, Marina Borschiwer, Melissa Bothe, Alisa Fuchs, Sebastiaan H Meijsing

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Verena ThormannMax Planck Institute for Molecular Genetics, Berlin, Germany.
Laura V GlaserMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-4495-9032
Maika C RothkegelMax Planck Institute for Molecular Genetics, Berlin, Germany.
Marina BorschiwerMax Planck Institute for Molecular Genetics, Berlin, Germany.
Melissa BotheMax Planck Institute for Molecular Genetics, Berlin, Germany.
Alisa FuchsMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-0464-9064
Sebastiaan H MeijsingMax Planck Institute for Molecular Genetics, Berlin, Germany meijsing@molgen.mpg.de.ORCID 0000-0002-8095-1847
Max Planck Institute for Molecular Genetics · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glucocorticoid receptor (GR), a hormone-activated transcription factor, binds to a myriad of genomic binding sites yet seems to regulate a much smaller number of genes. Genome-wide analysis of GR binding and gene regulation has shown that the likelihood of GR-dependent regulation increases with decreased distance of its binding to the transcriptional start site of a gene. To test if we can adopt this knowledge to expand the repertoire of GR target genes, we used CRISPR/Cas-mediated homology-directed repair to add a single GR-binding site directly upstream of the transcriptional start site of each of four genes. To our surprise, we found that the addition of a single GR-binding site can be enough to convert a gene into a GR target. The gain of GR-dependent regulation was observed for two of four genes analyzed and coincided with acquired GR binding at the introduced binding site. However, the gene-specific gain of GR-dependent regulation could not be explained by obvious differences in chromatin accessibility between converted genes and their non-converted counterparts. Furthermore, by introducing GR-binding sequences with different nucleotide compositions, we show that activation can be facilitated by distinct sequences without obvious differences in activity between the GR-binding sequence variants we tested. The approach to use genome engineering to build genomic response elements facilitates the generation of cell lines with tailored repertoires of GR-responsive genes and a framework to test and refine our understanding of the

Indexed as

AnimalsBinding SitesCell Line, TumorChromatinChromatin ImmunoprecipitationCRISPR-Cas SystemsGene EditingGene Expression RegulationHumansProtein BindingRatsReceptors, GlucocorticoidRegulatory Elements, TranscriptionalResponse ElementsRNA-SeqTranscriptional ActivationChromatinglucocorticoid receptor alphaReceptors, Glucocorticoid

Identifiers

PMID30867223
PMCPMC6417287
OpenAlexW2950190910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.